Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 541560 of 20,252 grants

Active NON-SBIR/STTR RPGS
Leveraging Project ECHO for improved cervical cancer screening in Ethiopia: An implementation study of integrated HPV selfsampling in HIV care centers
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2024 – 2029

PROJECT ABSTRACT Each year, more than 500,000 women are diagnosed with cervical cancer (CxCa), a preventable cancer caused by human papillomavirus (HPV) that disproportionately bur...

$6.29M
USD
Active NON-SBIR/STTR RPGS
Accelerated Brachytherapy Forward Chemoradiation Therapy (ABC-RT) for Cervical Cancer
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

PROJECT SUMMARY Survival from cervical cancer is stagnating in the United States. Despite many intervening clinical trials, the standard of care (SOC) definitive chemoradiation the...

$6.35M
USD
Active NON-SBIR/STTR RPGS
Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PROJECT SUMMARY Treatment with immune checkpoint inhibitors (ICI) has been revolutionary in melanoma and other cancers. However, only a subset of patients will have durable respons...

$6.78M
USD
Completed SBIR-STTR RPGS
Preclinical Studies to Develop an Eya2 Tyr Phosphatase Inhibitor as a Novel Medulloblastoma Therapeutic
NATIONAL CANCER INSTITUTE Sieyax, Llc United States 2024 – 2025

Medulloblastoma (MB) is the most common malignant brain tumor in children. For decades, there have not been significant advances in the treatment for MB, which still includes surge...

$4M
USD
Active SBIR-STTR RPGS
Activity-based Sensor Peptides for Direct, High-throughput, and Kinetic Quantitation of Oncogenic Protein Kinases in Unfractionated Cell and Tissue Samples
NATIONAL CANCER INSTITUTE Assayquant Technologies, Inc United States 2024 – 2026

PROJECT SUMMARY 30 lines Protein kinases catalyze selective and timely protein phosphorylation and are essential for the normal function of all cells. Unregulated kinase activity i...

$10.93M
USD
Completed SBIR-STTR RPGS
Engineering ex vivo breast tumors in human breast tissue to address racial disparities in HR-/ERBB2+ breast cancer
NATIONAL CANCER INSTITUTE Keliomics, Inc United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT Black women are 42% more likely to die from breast cancer than White women. While social, economic, structural, and cultural factors contribute to this dis...

$3.99M
USD
Active NON-SBIR/STTR RPGS
Assessment of strategies for targeting transcriptional co-activators in colorectal cancer
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2024 – 2029

Project Summary: PGC-1 family proteins (PGC-1α, PGC-1β, and PPRC1) are transcriptional coactivators that act as central hubs to coordinate diverse cellular inputs to promote the tr...

$4.39M
USD
Active NON-SBIR/STTR RPGS
3D Proteomics at Single Cell Resolution with Covalent Protein Painting (CPP)
NATIONAL CANCER INSTITUTE Scripps Research Institute, The United States 2024 – 2027

Project Summary/Abstract Somatic mutations alter the folding and therewith function of oncogene and tumor suppressor proteins. The alterations in protein structure drive malignant...

$2.4M
USD
Active NON-SBIR/STTR RPGS
Tuning KITv CAR T cells for the solid tumor environment
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

PROJECT ABSTRACT We developed and translated CD28 costimulated chimeric antigen receptor (M28z CARs) T cells that target mesothelin(MSLN), a cancer-associated antigen that is overe...

$6.55M
USD
Active NON-SBIR/STTR RPGS
Dissecting a novel tumor-promoting axis in cholangiocarcinoma
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2024 – 2029

There is an urgent need to identify effective treatments for intrahepatic cholangiocarcinoma (CCA), a highly desmoplastic tumor of the bile ducts with a five-year survival rate of...

$6.12M
USD
Active OTHER RESEARCH-RELATED
Automatic integrated biomarkers to improve prediction of lung cancer outcomes
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Research. Non-small cell lung cancer (NSCLC) is the world’s deadliest cancer, but patients with NSCLC can have dramatically different outcomes, illuminatin...

$2.56M
USD
Active SBIR-STTR RPGS
Immunotherapy to deplete key Treg subsets in solid tumors
NATIONAL CANCER INSTITUTE Sonoval Llc United States 2024 – 2026

Abstract Solid tumors such as non-small cell lung cancer and melanoma afflict more than 250,000 Americans per year. While immunotherapies such as checkpoint inhibitors (CPIs) have...

$12.94M
USD
Active NON-SBIR/STTR RPGS
Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

OVERALL: ABSTRACT Diffuse large B-cell lymphoma (DLBCL) is an aggressiveand clinically heterogeneous malignancy derived from B-cells transiting the germinal center (GC) reaction. I...

$25.61M
USD
Active NON-SBIR/STTR RPGS
Admin Core
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

CORE A: ADMINISTRATIVE CORE: PROJECT SUMMARY/ABSTRACT The responsibilities of the Administrative Core include monitoring and planning of scientific activities, providing scientific...

Active NON-SBIR/STTR RPGS
Project 1 Melnick
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

PROJECT 1: ABSTRACT One of the critical unmet needs from both the scientific and therapeutic standpoints in the B-cell lymphoma field is understanding how these tumors evade the no...

Active NON-SBIR/STTR RPGS
Project 2 Josefowicz
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

PROJECT 2: SUMMARY/ABSTRACT Activated B cell-like diffuse large B-cell lymphoma (ABC-DLBCL) and Epstein Barr virus associated viral lymphomas (EBV+ lymphoma) have in common that th...

Active NON-SBIR/STTR RPGS
Project 3 Cerchietti
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

PROJECT 3: SUMMARY/ABSTRACT This project focus in the biology of diffuse large B-cell lymphoma (DLBCL) in older individuals (i.e., patients 75-years or older). Based on findings in...

Active NON-SBIR/STTR RPGS
Project 4 Green-Davis
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

PROJECT 4: ABSTRACT Diffuse large B-cell lymphoma (DLBCL) is the most common form lymphoma and is conventionally treated with a combination of chemotherapeutics with the anti-CD20...

Active NON-SBIR/STTR RPGS
Elucidating the mechanism of Ga13 mediated tumor suppression in pancreatic cancer
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2024 – 2028

RESEARCH SUMMARY The heterotrimeric G proteins transduce signals from the G protein-coupled receptors (GPCRs), the largest class of cell surface proteins that regulate a wide varie...

$4.05M
USD
Active NON-SBIR/STTR RPGS
Core 1: Lymphoma models
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

CORE 1 LYMPHOMA MODEL SYSTEMS: SUMMARY/ABSTRACT The Lymphoma Model System core (LMSC) will assemble and characterize the reagents critical for this proposal, including the vast arr...